Janiczek Wealth Management, LLC Axsome Therapeutics, Inc. Transaction History
Janiczek Wealth Management, LLC
- $475 Million
- Q2 2024
A detailed history of Janiczek Wealth Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 1,213 shares of AXSM stock, worth $126,709. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,213
Previous 1,213
-0.0%
Holding current value
$126,709
Previous $96,000
1.04%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
353Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$423 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$408 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$345 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$153 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$145 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.48B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...